OXFORD BIOMEDICA (UK) LIMITED – MIA 17479
| Authorisation Number | UK MIA 17479 |
| Category | MIA |
| Holder | OXFORD BIOMEDICA (UK) LIMITED |
| Registered Address | OXFORD BIOMEDICA (UK) LIMITED, WINDRUSH COURT, TRANSPORT WAY, OXFORD, OX4 6LT, UNITED KINGDOM |
| Authorisation Date | Mar 12, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 4 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.4 1.1.3 1.3 1.3.1 1.3.1.2 1.3.1.3 1.3.1.4 1.3.1.5 1.3.2 1.3.2.2 1.3.2.3 1.3.2.4 1.3.2.5 1.4 1.4.1 1.4.1.3 1.4.1.4 1.4.2 1.4.2.1 1.5 1.5.2 1.6 1.6.1 1.6.2 1.6.3 1.6.4 |
| MHRA Link | View on MHRA Website |
Sites (4)
OXFORD BIOMEDICA (UK) LIMITED
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.6 — Quality control testing
1.6.3 — Chemical/Physical
1.6.4 — Biological
OXFORD BIOMEDICA (UK) LIMITED
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.5 — Biotechnology products
1.4 — Other products or manufacturing activity
1.4.1 — Manufacture of:
1.4.1.3 — Other
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
OXFORD BIOMEDICA (UK) LIMITED
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.1 — Sterile Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.3 — Batch certification
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.5 — Biotechnology products
1.4 — Other products or manufacturing activity
1.4.1 — Manufacture of:
1.4.1.3 — Other
1.4.1.4 — Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc)
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.1 — Microbiological: sterility
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
OXFORD BIOMEDICA (UK) LIMITED
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.5 — Biotechnology products
1.4 — Other products or manufacturing activity
1.4.1 — Manufacture of:
1.4.1.3 — Other
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
Content Preview
The source document is available on KeyPedia. Sign in to view.